79 related articles for article (PubMed ID: 19718517)
1. Identification of the specific binding proteins of bioactive small compound using affinity resins.
Tanaka A
Methods Mol Biol; 2009; 577():181-95. PubMed ID: 19718517
[TBL] [Abstract][Full Text] [Related]
2. A versatile method of identifying specific binding proteins on affinity resins.
Yamamoto K; Yamazaki A; Takeuchi M; Tanaka A
Anal Biochem; 2006 May; 352(1):15-23. PubMed ID: 16540075
[TBL] [Abstract][Full Text] [Related]
3. Selective elution of target protein from affinity resins by a simple reductant with a thiol group.
Mabuchi M; Haramura M; Shimizu T; Nishizaki T; Tanaka A
Bioorg Med Chem Lett; 2010 Dec; 20(24):7361-4. PubMed ID: 21067925
[TBL] [Abstract][Full Text] [Related]
4. Isolating the whole complex of target proteins of FK506 using affinity resins from novel solid phases.
Takahashi T; Shiyama T; Mori T; Hosoya K; Tanaka A
Anal Bioanal Chem; 2006 May; 385(1):122-7. PubMed ID: 16601955
[TBL] [Abstract][Full Text] [Related]
5. Improvement of solid material for affinity resins by application of long PEG spacers to capture the whole target complex of FK506.
Mabuchi M; Shimizu T; Ueda M; Mitamura K; Ikegawa S; Tanaka A
Bioorg Med Chem Lett; 2015 Jul; 25(14):2788-92. PubMed ID: 26025877
[TBL] [Abstract][Full Text] [Related]
6. Improvement of monolithic solid material by utilization of spacer for identification of the target using affinity resins.
Iwaoka E; Mori T; Shimizu T; Hosoya K; Tanaka A
Bioorg Med Chem Lett; 2009 Mar; 19(5):1469-72. PubMed ID: 19201607
[TBL] [Abstract][Full Text] [Related]
7. An easy preparation of 'monolithic type' hydrophilic solid phase: capability for affinity resin to isolate target proteins.
Mori T; Takahashi T; Shiyama T; Tanaka A; Hira N; Tanaka N; Hosoya K
Bioorg Med Chem; 2006 Aug; 14(16):5549-54. PubMed ID: 16682207
[TBL] [Abstract][Full Text] [Related]
8. A quantitative analysis and chemical approach for the reduction of nonspecific binding proteins on affinity resins.
Tamura T; Terada T; Tanaka A
Bioconjug Chem; 2003; 14(6):1222-30. PubMed ID: 14624639
[TBL] [Abstract][Full Text] [Related]
9. [Identification of specific binding protein using affinity resins for discovery of drug target].
Tanaka A
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1576-81. PubMed ID: 21089591
[No Abstract] [Full Text] [Related]
10. Selective ligand purification using high-performance affinity beads.
Ohtsu Y; Ohba R; Imamura Y; Kobayashi M; Hatori H; Zenkoh T; Hatakeyama M; Manabe T; Hino M; Yamaguchi Y; Kataoka K; Kawaguchi H; Watanabe H; Handa H
Anal Biochem; 2005 Mar; 338(2):245-52. PubMed ID: 15745744
[TBL] [Abstract][Full Text] [Related]
11. Chemical and biological investigation of N-hydroxy-valdecoxib: An active metabolite of valdecoxib.
Erdélyi P; Fodor T; Varga AK; Czugler M; Gere A; Fischer J
Bioorg Med Chem; 2008 May; 16(9):5322-30. PubMed ID: 18353655
[TBL] [Abstract][Full Text] [Related]
12. Identification of FKBP-related proteins with antibodies of predetermined specificity and isolation by FK 506 affinity chromatography.
Rosborough SL; Fleming M; Nelson PA; Boger J; Harding MW
Transplant Proc; 1991 Dec; 23(6):2890-3. PubMed ID: 1721306
[No Abstract] [Full Text] [Related]
13. Identification of molecular target of AMP-activated protein kinase activator by affinity purification and mass spectrometry.
Kosaka T; Okuyama R; Sun W; Ogata T; Harada J; Araki K; Izumi M; Yoshida T; Okuno A; Fujiwara T; Ohsumi J; Ichikawa K
Anal Chem; 2005 Apr; 77(7):2050-5. PubMed ID: 15801737
[TBL] [Abstract][Full Text] [Related]
14. Affinity-purification of Transferrin-binding protein B under nondenaturing conditions.
Krell T; Chevalier M; Lissolo L
Protein Expr Purif; 2002 Apr; 24(3):323-8. PubMed ID: 11922747
[TBL] [Abstract][Full Text] [Related]
15. Importance of surface properties of affinity resin for capturing a target protein, cyclooxygenase-1.
Mori T; Kubo T; Kaya K; Hosoya K
Bioorg Med Chem; 2009 Feb; 17(4):1587-99. PubMed ID: 19167894
[TBL] [Abstract][Full Text] [Related]
16. Efficient purification of recombinant proteins fused to maltose-binding protein by mixed-mode chromatography.
Cabanne C; Pezzini J; Joucla G; Hocquellet A; Barbot C; Garbay B; Santarelli X
J Chromatogr A; 2009 May; 1216(20):4451-6. PubMed ID: 19329121
[TBL] [Abstract][Full Text] [Related]
17. Development of chemically stable solid phases for the target isolation with reduced nonspecific binding proteins.
Takahashi T; Shiyama T; Hosoya K; Tanaka A
Bioorg Med Chem Lett; 2006 Jan; 16(2):447-50. PubMed ID: 16290149
[TBL] [Abstract][Full Text] [Related]
18. Immunological identification of a 50 kDa Mr FK506-binding immunophilin as a component of the non-DNA binding, hsp90 and hsp70 containing, heterooligomeric form of the chick oviduct progesterone receptor.
Renoir JM; Pahl A; Keller U; Baulieu EE
C R Acad Sci III; 1993 Dec; 316(12):1410-6. PubMed ID: 7522118
[TBL] [Abstract][Full Text] [Related]
19. Bifunctional molecules evade cytochrome P(450) metabolism by forming protective complexes with FK506-binding protein.
Marinec PS; Lancia JK; Gestwicki JE
Mol Biosyst; 2008 Jun; 4(6):571-8. PubMed ID: 18493655
[TBL] [Abstract][Full Text] [Related]
20. Chemical proteomics for drug discovery based on compound-immobilized affinity chromatography.
Katayama H; Oda Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Aug; 855(1):21-7. PubMed ID: 17241823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
